ALMU AELUMA INC
Information Technology · Russell 2000
Next earnings: Thu 12 Nov 2026 · during market hours
What 8 analyst firms say about AELUMA INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 5 reports on ALMU from 5 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Freedom Broker raised its target from $23.00 (set 31 Mar 2026) to $25.00 on 17 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Benchmark | David Williams | Buy | 3 Mar 2026 | 25.00 USD |
| Craig-Hallum | Richard C Shannon | Buy | 17 Sep 2026 | 22.00 USD |
| Freedom Capital | Unnamed analyst | Buy | 31 Mar 2026 | — |
| Freedom Capital Markets | Danial Yermakhan | Buy | 17 Sep 2026 | 25.00 USD |
| Northland Capital Markets | Tim Savageaux | Buy | 2 Nov 2026 | 16.00 USD |
| UBS | Unnamed analyst | Buy | 3 Mar 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 3 Nov 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:23 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.